Adults With ADHD Exhibit Camouflaging Behavior
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 21, 2024 -- Adults with attention-deficit/hyperactivity disorder (ADHD) exhibit camouflaging behavior, but to a lesser extent than those with autism, according to a study published online Feb. 7 in Autism Research.
Noting that camouflaging is thought to be an important reason for late autism diagnoses and mental health difficulties, Wikke J. van der Putten, from the Autism Outpatient Clinic in Amsterdam, and colleagues examined whether adults with ADHD could camouflage. Adults (aged 30 to 90 years) completed the Dutch Camouflaging Autistic Traits Questionnaire, the ADHD Self-Report, and the Autism Spectrum Quotient; differences in camouflaging were examined for adults with ADHD, autism, and a comparison group (105 adults in each group). In addition, the question of whether autism and ADHD traits explained camouflaging levels was examined in 477 adults with an autism and/or ADHD diagnosis.
The researchers found that relative to the comparison group, adults with ADHD scored higher on total camouflaging and on the assimilation subscale. However, relative to adults with autism, adults with ADHD scored lower on total camouflaging and the compensation and assimilation subscales. Independent of diagnosis, autism traits were a significant predictor of camouflaging, but ADHD traits were not.
"More in-depth studies are necessary to fully grasp how people with ADHD camouflage, whether this differs from camouflaging in autistic adults, and to what extent camouflaging may be a source for mental health difficulties and late diagnoses in people with ADHD," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
ADHD Meds May Help Control Opioid Use Disorder in Pregnancy
TUESDAY, June 25, 2024 -- Psychostimulants may help opioid use disorder (OUD) outcomes in pregnant women, according to a study published online June 11 in Nature Mental...
FDA Approves First Liquid, Nonstimulant ADHD Treatment, Onyda XR
MONDAY, June 3, 2024 -- The U.S. Food and Drug Administration has approved once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for...
Pharmacological Treatment of ADHD May Cut Some Forms of Criminality
WEDNESDAY, May 29, 2024 -- Pharmacological treatment may reduce some types of criminality among adolescents and young adults with attention-deficit/hyperactivity disorder (ADHD)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.